Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates

Pediatrics

Volumn 108, Issue 2 II, 2001, Pages 329-332

  Ören, Hale ^a   Duman, Nuray ^a   Abacioglu, Hakan ^a   Özkan, Hasan ^a   Irken, Gülersu ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Macrophage colony stimulating factor; Monocyte; Neonate; Sepsis; Thrombocytopenia

Indexed keywords

COLONY STIMULATING FACTOR 1; HEMOPOIETIC GROWTH FACTOR;

ARTICLE; BIRTH WEIGHT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; NEWBORN; NEWBORN CARE; NEWBORN HYPOXIA; NEWBORN SEPSIS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VEIN PUNCTURE;

ANOXIA; ASPHYXIA NEONATORUM; BIRTH WEIGHT; BLOOD PLATELETS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTES; PLATELET COUNT; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; THROMBOCYTOPENIA;

EID: 0034880050     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.108.2.329     Document Type: Article

References (50)

1. Hematopoietic growth factors
2. The human hematopoietic colony-stimulating factors
3. Regulation of hematopoiesis
4. Therapeutic implications of dysregulated colony-stimulating factor expression in neonates
5. Hematopoietic growth factor levels in term and preterm infants
6. Hematopoiesis in the fetus and neonate
7. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates
8. Plasma granulocyte-colony stimulating factor concentrations (G-CSF) in the early neonatal period
9. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections
10. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery
11. G-CSF, GM-CSF and IL-6 levels in cord blood: Diminished increase of G-CSF and IL-6 in preterm with perinatal infection compared to term neonates
12. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns
13. Colony-stimulating factor 1 levels in the human newborn infant
14. Production and expression of granulocyte- and macrophage-colony-stimulating factors in newborns: Their roles in leukocytosis at birth
15. Increased macrophage-colony stimulating factor levels in neonates with perinatal complications
16. Colony-stimulating factor-1 expression in the human fetus and newborn
17. A mononuclear phagocyte lineage-specific hemopoietic growth factor
18. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumour necrosis factor, and colony stimulating activity
19. Production of lymphocyte-activating factor (interleukin 1) by macrophages activated with colony-stimulating factors
20. Characterization of murine bone marrow and spleen derived stromal cells. Analysis of leukocyte marker and growth factor mRNA transcript levels
21. Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells
22. Expression of colony-stimulating factor-1 in the human uterus and placenta
23. The role of M-CSF and GM-CSF in fostering placental growth, fetal growth and fetal survival
24. Treatment of mice with macrophage-colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta and gamma interferons
25. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo
26. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor
27. Clinical toxicity of cytokines used as haemopoietic growth factors
28. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates
29. Transient thrombocytopenia produced by administration of macrophage colony-stimulating factor: Investigations of the mechanism
30. Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura
31. High dose intravenous gamma globulin reduces macrophage colony-stimulating factor levels in idiopathic thrombocytopenic purpura
32. Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation
33. Human macrophage colony stimulating factor levels are elevated in pregnancy and in immune thrombocytopenia
34. The definition of acute perinatal asphyxia
35. American College of Chest Physicians Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure for the use of innovative therapies in sepsis
36. Urinary nitrite excretion in low birth weight neonates with systemic inflammatory response syndrome
37. Early and late neonatal septicemia
38. High serum human macrophage colony stimulating factor level during pregnancy
39. Within-day and day-to-day variations of serum M-CSF levels in healthy volunteers
40. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay
41. Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony stimulating factor
42. Endogenous haemopoietic growth factors in neutropenia and infection
43. Production of macrophage-, granulocyte-, granulocyte-macrophage- and multicolony-stimulating factor by peripheral blood cells
44. Granulocyte colony-stimulating factor to prevent the progression of systemic nonrespondiveness in systemic inflammatory response syndrome and sepsis
45. Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents
46. Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia
47. Thrombocytopenia in the neonate
48. Platelet disorders in newborn infants: Diagnosis and management
49. Review: Management of thrombocytopenia in neonates
50. Involvement of interferon-γ and macrophage colony-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults